Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma

Abstract

Changes in ANA, especially alterations in autoantibody specificities, are seen infrequently in systemic autoimmune diseases. It is possible that in HCC such changes in ANA might reflect autoimmune responses to intranuclear antigens that are perturbed in cellular transformation.